Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Neuro-Oncology
What dose constraint do you use for the spinal cord and/or cauda equina for a spinal meningioma?
Does your constraint differ based on region of the spinal cord?
Answer from: Radiation Oncologist at Academic Institution
Presumably WHO 1. 50.4/28 fractions. Good control. Low risk of injury.
Comments
Radiation Oncologist at Shariati Hospital, Tehran Universit of Medical Sciences
Would you accept a higher dose to cauda equine com...
Radiation Oncologist at Vanderbilt-Ingram Cancer Center
Yes - how much more I would accept is dependent on...
Radiation Oncologist at Munson Medical Center
The area of the cord/cauda equina definitely matte...
10219
10247
10248
Sign in or Register to read more
18990
Related Questions
Is it reasonable to extrapolate data from Glioblastoma and discuss Tumor Treating Fields in patients with Grade 4, IDH Mutant, astrocytomas?
How do you proceed with radiation planning for preliminary suspected high grade gliomas after surgery when there is a delay in final molecular diagnosis?
How do you use Boswellia for radiation necrosis?
For patients with metastatic cancer on a systemic therapy regimen that includes bevacizumab, are you comfortable treating brain metastases (SRS or WBRT) without holding bevacizumab?
What dose would you consider for a patient who received 59.4 Gy 18 years ago for a glioma of the right frontal lobe who is now S/P gross total resection for a high-grade glioma in the same area?
What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?
How do you manage an intramedullary benign nerve sheath tumor post sub-total resection seen on post-operative MRI?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
Would you manage a subtotally resected pilocytic astrocytoma with deleted CDKN2A differently than one with intact CDKN2A?
Is there a time interval after which you would not offer adjuvant radiotherapy for a malignant, grade 3 meningioma?
Would you accept a higher dose to cauda equine com...
Yes - how much more I would accept is dependent on...
The area of the cord/cauda equina definitely matte...